Comparative evaluation of the protective efficacy of two formulations of a recombinant Chlamydia abortus subunit candidate vaccine in a mouse model

Highlights • The ability of recombinant C. abortus Pmp18D formulated in CpG + FL adjuvants or Vibrio cholerae ghosts (VCGs) to induce innate and cross protective immunity against genital C. abortus infection was evaluated. • VCG-delivered rPmp18D was more effective than CpG + FL in stimulating the D...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine Vol. 33; no. 15; pp. 1865 - 1872
Main Authors: Pan, Qing, Pais, Roshan, Ohandjo, Adaugo, He, Cheng, He, Qing, Omosun, Yusuf, Igietseme, J.U, Eko, F.O
Format: Journal Article
Language:English
Published: Netherlands Elsevier Ltd 08-04-2015
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • The ability of recombinant C. abortus Pmp18D formulated in CpG + FL adjuvants or Vibrio cholerae ghosts (VCGs) to induce innate and cross protective immunity against genital C. abortus infection was evaluated. • VCG-delivered rPmp18D was more effective than CpG + FL in stimulating the DC expression of molecules critically involved in T cell activation and differentiation, and activation of innate immune signaling involving TLRs and NLRP3 inflammasome. • VCG-delivered rPmp18D elicited more robust antigen-specific cellular and humoral immune responses in mice compared to CpG + FL. • Vaccine delivery with VCG induced superior cross-protective immunity than delivery with a combination of CpG1826 and FL. • The vaccine delivery and immunomodulatory capacity of VCG is thus superior to that of CpG + FL adjuvants.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2015.02.007